Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Innovating global regulatory frameworks for generative AI in medical devices is an urgent priority

Open access

Abstract

The integration of generative AI (GenAI) and large language models (LLMs) in healthcare presents both unprecedented opportunities and challenges, necessitating innovative regulatory approaches. In this perspective, we discuss the risks of GenAI and LLM-based medical devices, the limitations of current medical device regulation frameworks when applied to GenAI or LLMs, and advocate for global collaboration in regulatory science research through engaging multidisciplinary expertise and focusing on the needs of diverse populations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41746-026-02552-2

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 An illustration of the different phases of the total product life cycle for LLM-based medical devices. This figure illustrates the TPLC of an LLM-based medical device, comprising different phases from planning and design to real-world performance evaluations. However, LLMs pose unique considerations and regulatory challenges at each phase, such as a lack of standardised evaluation metrics to assess performance.
Fig. 1 An illustration of the different phases of the total product life cycle for LLM-based medical devices. This figure illustrates the TPLC of an LLM-based medical device, comprising different phases from planning and design to real-world performance evaluations. However, LLMs pose unique considerations and regulatory challenges at each phase, such as a lack of standardised evaluation metrics to assess performance.CC BY-NC-ND · PubMed Central
Fig. 2 The healthcare AI supply chain. Data, model (or product), IT implementation capabilities and infrastructure and hardware integration all form parts of the healthcare AI supply chain. Different regulations, framework and governing bodies oversee parts, if not all segments of the supply chain.
Fig. 2 The healthcare AI supply chain. Data, model (or product), IT implementation capabilities and infrastructure and hardware integration all form parts of the healthcare AI supply chain. Different regulations, framework and governing bodies oversee parts, if not all segments of the supply chain.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 3

  1. OECD. Regulatory Sandboxes in Artificial Intelligence, Vol. 356 (OECD Digital Economy Papers, 2023).
  2. OpenAI. Learning to Reason with LLMs. Vol. 16 December 2024 (https://openai.com/index/learning-to-reason-with-llms/, September 12, 2024).
  3. International Medical Device Regulators Forum. Working Groups: Artificial Intelligence/Machine Learning-enabled, Vol. 2024 (IMDRF, 2024); https://www.imdrf.org/working-groups/artificial-intelligencemachine-learning-enabled

Cited by

See all 22

Metadata

Authors
Ong, J. C. L., Ning, Y., Liu, M., Ma, Y., Zhao, L., Singh, K., Chang, R. T., Vogel, S., Lim, J. C. W., Tan, I. S. K., Freyer, O., Gilbert, S., Bitterman, D. S., Liu, X., Denniston, A. K., & Liu, N.
Affiliations
  • Singapore General Hospital (SG)
  • Duke-NUS Medical School (SG)
  • University of California, San Francisco (US)
  • Stanford Medicine (US)
  • National University of Singapore (SG)
  • Else Kröner Fresenius Center for Digital Health (DE)
  • Brigham and Women's Hospital (US)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
Corresponding author
Liu, Nan
Venue
npj Digital Medicine
Published
2026-03-19
Volume
9
Issue
1
ISSN
2398-6352 (ISSN-L)
OpenAlex
W7138919120
Cited by
7
References
62
Citations by year
2026: 7
FWCI
4.29
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Digital Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
  • Social Sciences › Law › Digitalization, Law, and Regulation
Keywords
generative AI, large language models, medical devices, medical device regulation, regulatory framework, regulatory science, AI risks, artificial intelligence in healthcare

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Innovating global regulatory frameworks for generative AI in medical devices is an urgent priority. https://app.cochat.ai/papers/10.1038/s41746-026-02552-2
The paper
Ong, J. C. L., Ning, Y., Liu, M., Ma, Y., Zhao, L., Singh, K., Chang, R. T., Vogel, S., Lim, J. C. W., Tan, I. S. K., Freyer, O., Gilbert, S., Bitterman, D. S., Liu, X., Denniston, A. K., & Liu, N. (2026). Innovating global regulatory frameworks for generative AI in medical devices is an urgent priority. npj Digital Medicine. https://doi.org/10.1038/s41746-026-02552-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.